Spurred by several trends including the patent cliff, new product launches and changes in healthcare, the contract packaging market is looking at sustained growth in the years ahead Read More >
More than $60 billion worth of patents on biological products are expiring before 2020, representing a major opportunity for the pharmaceutical industry. Read More >
Moving forward clinical studies will have to include a comparative assessment of
pharmacokinetics and immunogenicity to the original reference biologic drug Read More >
As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important Read More >
(Based on 2014 Sales, in $U.S. Millions) Read More >
We exceed expectations
Welcome to Contract Pharma’s Sixteenth Annual Salary Survey!
Amgen v. Sandoz biosimilars litigation could impact the industry for years to come
Applied Drug Delivery Institute recognizes life science innovators
Employment Type: Full-time
Herein are the results of our 2015 Annual Outsourcing Survey, where we call on you, the readers.
With the first DSCSA serialization deadline just two years away, how should contract manufacturers and packagers begin to pla
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.